Clinical Analysis of 21 Cases with Combined Hepatocellular and Cholangiocellular Carcinoma Treated by Liver Transplantation

吴迪,朱志军,王建,张雅敏,郑虹,邓永林,潘澄,沈中阳
DOI: https://doi.org/10.3760/cma.j.issn.1673-4203.2013.08.006
2013-01-01
Abstract:Objective To evaluate the therapeutic effect of liver transplantation on combined hepatocellular and cholangiocellular carcinoma (cHCC-CC) and to analyze the clinical and pathological factors affecting the prognosis.Methods Retrospectively analyzed the clinical and pathological data of 21 cases with cHCC-CC who underwent orthotopic liver transplantation and 8 cases with cHCC-CC who without surgical therapy.The outcome of the patients classified by different factors was compared using a Log-Rank test.Prognosis was analyzed by COX multivariate model.Survival analysis was performed using Kaplan-Meier methods.Results In peroperative period,survival rate was 100%.The postoperative survival time was from 1 to 103 months,the median survival time is 23 months.Postoperative tumor free survival time was from 3 to 103 months,the median survival time is 15 months.The overall cumulative survival rates of 1 year,2 years,3 years,5 years were 69%,58%,38% and 38%,the cumulative tumor-free survival rates of 1 year,2 years,3 years,5 years were 63%,52%,38% and 38%.Univariate analysis showed that preoperative accompanied with liver cirrhosis,tumors total diameter,lymph node metastasis,portal macrovascular invasion and Allen type mixed type may be a poor prognostic factors (P < 0.05).Conclusions Liver transplantation is an effective method to treat cHCC-CC.Strict screening of potential liver transplantation candidates with cHCC-CC can help reduce tumor recurrence and prolong the survival period.
What problem does this paper attempt to address?